Bacterial Resistance
8
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
Antistaphylococcal Betalactam and Emergence of Resistance
Bacterial Microbiota Characterization on Implant-supported PEEK and Titanium Provisional Abutments
Community Epidemiology and Typology of Third-generation Cephalosporins Resistant Enterobacteriaceae in Reunion Island
Impact of Number of Rank of B-lactam Antibiotics on Emergence on Multidrug Resistant Bacteria
Bacterial Resistance in Patients Receiving Post-Intravitreal Injection Antibiotics
Study to Assess Management and Outcomes of Hospitalised Patients With Complicated UTI (RESCUING)
Reduction of Bacterial Resistance With Inhaled Antibiotics in the Intensive Care Unit
SATURN 04 Nosocomial Acquisition Study